Parliamentary.ai


by Munro Research

Supervised Drug Consumption Facilities Bill


Official Summary

A Bill to make provision about supervised drug consumption facilities; to make it lawful to take controlled substances within such facilities in specified circumstances; and for connected purposes

Summary powered by AnyModel

Overview

This bill proposes the legalisation of supervised drug consumption facilities (SDCFs) in the UK. These facilities would provide a medically supervised environment where individuals can use controlled substances, aiming to reduce harm and deaths associated with drug use.

Description

The bill outlines the establishment and operation of SDCFs. Local authorities can apply for a license from the relevant Secretary of State (or equivalent in devolved nations) to operate these facilities. Applications require details on personnel, premises suitability, and operational protocols. The Secretary of State will consider various factors, including advice from the NHS and local drug-related statistics before granting licenses. Licenses may be granted, refused, renewed, or revoked under certain conditions specified in regulations. Crucially, the bill amends the Misuse of Drugs Act 1971 to exempt authorized users and staff of licensed facilities from prosecution for possession or supply of controlled drugs within the facility.

The bill mandates annual reports to Parliament on drug-related deaths, on-street injecting, needle infections, and the impact of SDCFs on these issues. Devolved administrations (Scotland, Wales, and Northern Ireland) have roles in the regulatory process.

Government Spending

The bill states that any expenditure incurred by the Secretary of State under the Act, and any increase in sums payable under other acts, will be paid from public funds. No specific figures are provided within the bill itself.

Groups Affected

  • People who use drugs: May benefit from reduced overdose risk, access to healthcare, and support services.
  • Local authorities: Will have the responsibility to apply for and manage licenses for SDCFs, potentially incurring costs and requiring additional resources.
  • Healthcare professionals: Will play a vital role in overseeing and providing medical support within the facilities.
  • Police and law enforcement: Will see a shift in approach to drug use, potentially with a focus on harm reduction rather than solely enforcement.
  • Local communities: May have concerns or support regarding the establishment of SDCFs in their area.
Full Text

Powered by nyModel

DISCLAIMER: AI technology is not 100% accurate and summaries may contain errors, use at your own risk. Munro Research holds the copyright for all summaries found this website. Reproduction for non-commercial purposes is permitted but must be displayed alongside a link to this website. Contact info@munro-research to license commercially.